amg and folksIMHO 3m and the whole patch thing will lead to...

amg and folks

IMHO 3m and the whole patch thing will lead to nothing, just as i said it would in early April. IMHO 3m are only looking at supplying the hardware for this proposed patch

quote form the ann in April

"allows OBJ to offer a full range of development and production programs to partner projects supported by 3M Drug Delivery Systems technology and production expertise"

end quote

It is, and was then still only "in Vitro" work which means they are yet to get it out of a test tube, which means the patch is still pre clinical and a decade away from being on the market at best, and thats even it it works at all, which imho it does not

to support this, If it did, 3m and Obj would move heaven and earth to accelerate out of in vitro tests, IMHO the whole thing is a ruse in saying 3 m are busy, if something has legs it gets funded out of in vitro to begin with and immediatley

Its when you hit the Human trials the $$$ costs come in.

So imho i would not expect any good news come October

The FMCG/FIM thing may have legs, but the $$$$$ involved in it will be tiny compared to a Pharma application

And with a billion shares on offer, i wouldnt expect much out of it

Again all IMHO and DYOR